山东新华制药股份有限公司

投资者关系

信息透明，信任同行

2025-06-11

Overseas Regulatory Announcement-Announcement on Sacubitril Valsartan Sodium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

2025-06-11

海外監管公告-關於獲得沙庫巴曲纈沙坦鈉化學原料藥上市申請批准通知書的公告

2025-06-05

Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Soft Capsules Having Obtained Drug Registration Certificate

2025-06-05

海外監管公告-關於取得二十碳五烯酸乙酯軟膠囊藥品註冊證書的公告

2025-06-05

Overseas Regulatory Announcement-Announcement on Isavuconazonium Sulfate for Injection Having Obtained Drug Registration Certificate

2025-06-05

海外監管公告-關於取得注射用硫酸艾沙康唑藥品註冊證書的公告

2025-06-03

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025

2025-06-03

截至二零二五年五月三十一日止月份之股份發行人的證券變動月報表

2025-05-22

Overseas Regulatory Announcement-Announcement on Ibuprofen Suspension Drops Having Obtained Drug Registration Certificate

2025-05-22

海外監管公告-關於取得布洛芬混懸滴劑藥品註冊證書的公告